Characteristics of Escherichia coli biofilm production, genetic typing, drug resistance pattern and gene expression under aminoglycoside pressures

Environmental Toxicology and Pharmacology

Volumn 30, Issue 1, 2010, Pages 5-10

  Chen, Chaoxi ^a,b   Liao, Xiaoping ^a   Jiang, Hongxia ^a   Zhu, Hengqian ^a   Yue, Lei ^a   Li, Shujuan ^a   Fang, Binghu ^a   Liu, Yahong ^a  

^a Development and Safety Evaluation   (China)

^b SOUTHWEST UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Aminoglycosides; Biofilm forming ability; ERIC PCR (enterobacterial repetitive intergenic consensus based PCR); Multiple antibiotics resistance; QRT PCR

Indexed keywords

ACRA PROTEIN; AGN43 PROTEIN; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; APRAMYCIN; BACTERIAL PROTEIN; CEFTIOFUR; CRYSTAL VIOLET; CSGA PROTEIN; CSGD PROTEIN; DOXYCYCLINE; ENROFLOXACIN; FLORFENICOL; GENTAMICIN; OUTER MEMBRANE PROTEIN F; PGAA PROTEIN; RIFAMPICIN; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY;

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 77953356429     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.03.004     Document Type: Article

References (23)

1. Cerca N., Jefferson K.K., Maira-Litran T., Pier D.B., Kelly-Quintos C., Goldmann D.A., Azeredo J., Pier G.B. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of Staphylococcal poly-N-acetyl-β-(1-6)-glucosamine. Infect. Immun. 2007, 75:3406-3413.
2. Coquet L., Cosette P., Quillet L., Petit F., Junter G.A., Jouenne T. Occurrence and phenotypic characterization of Yersinia ruckeri strains with biofilm-forming capacity in a rainbow trout farm. Appl. Environ. Microbiol. 2002, 68:470-475.
3. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284:1318-1322.
4. Fontaine M.C., Smith D.G. Microbial biofilms: does breaking the microbes' community spirit hold the key to beating persistent mastitis?. Vet. J. 2006, 171:387-388.
5. Frank K.L., Reichert E.J., Piper K.E., Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 2007, 51:888-895.
6. Ganderton L., Chawla J., Winters C., Wimpenny J., Stickler D. Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur. J. Clin. Microbiol. Infect. Dis. 1992, 11:789-796.
7. Hoffman L.R., Dargenio D.A., Maccoss M.J., Zhang Z.Y., Jones R.A., Miller S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 2005, 436:1171-1175.
8. Kim Y., Wang X., Ma Q., Zhang X.S., Wood T.K. Toxin-antitoxin systems in Escherichia coli influence biofilm formation through YjgK (TabA) and fimbriae. J. Bacteriol. 2009, 191:1258-1267.
9. -ΔΔCT method. Methods 2001, 25:402-408.
10. Melchior M.B., Vaarkamp H., Fink-Gremmels J. Biofilms: a role in recurrent mastitis infections?. Vet. J. 2006, 171:398-407.
11. Moskowitz S.M., Foster J.M., Emerson J., Burns J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 2004, 42:1915-1922.
12. Naves P., Del Huelves L., Gracia M., Ruiz V., Blanco J., Dahbi G., Blanco M., Pontemdel C., Soriano F. Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb. Pathog. 2008, 45:86-91.
13. Pawar D.M., Rossman M.L., Chen J. Role of curli fimbriae in mediating the cells of enterohaemorrhagic Escherichia coli to attach to abiotic surfaces. J. Appl. Microbiol. 2005, 99:418-425.
14. Reisner A., Krogfelt K.A., Klein B.M., Zechner E.L., Molin S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J. Bacteriol. 2006, 188:3572-3581.
15. Rijavec M., Muller-Premru M., Zakotnik B., Zgur-Bertok D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J. Med. Microbiol. 2008, 57:1329-1334.
16. Ryu J.H., Beuchat L.R. Biofilm formation by Escherichia coli O157:H7 on stainless steel: effect of exopolysaccharide and curli production on its resistance to chlorine. Appl. Environ. Microbiol. 2005, 71:247-255.
17. Silva E., Leitao S., Tenreiro T., Pomba C., Nunes T., Lopes da Costa L., Mateus L. Genomic and phenotypic characterization of Escherichia coli isolates recovered from the uterus of puerperal dairy cows. J. Dairy Sci. 2009, 92:6000-6010.
18. Sommer P., Marin-Rouas C., Mettler E. Influence of the adherent population level on biofilm population, structure and resistance to chlorination. Food Microbiol. 1999, 16:503-515.
19. Stepanovic S., Vukovic D., Dakic I., Sacic B., Svabic-Vihovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J. Microbiol. Methods 2000, 40:175-179.
20. Suman E., Jose J., Varghese S., Kotian M.S. Study of biofilm production in Escherichia coli causing urinary tract infection. Indian J. Med. Microbiol. 2007, 25:305-306.
21. Uhlich G.A., Gunther N.W., Bayles D.O., Mosier D.A. The CsgA and Lpp proteins of an Escherichia coli O157:H7 strain affect HEp-2 cell invasion, motility, and biofilm formation. Infect. Immun. 2009, 77(4):1543-1552.
22. Wilson L.A., Sharp P.M. Enterobacterial repetitive intergenic consensus (ERIC) sequences in Escherichia coli: evolution and implications for ERIC-PCR. Mol. Biol. Evol. 2006, 23(6):1156-1168.
23. Yang W.Q., Shi L., Jia W.X., Yin X.L., Su J.Y., Kou Y.L., Xie Y., Shinodo S. Evaluation of the biofilm-forming ability and genetic typing for clinical isolates of Pseudomonas aeruginosa by enterobacterial repetitive intergenic consensus-based PCR. Microbiol. Immunol. 2005, 49:1057-1061.